Across TCGA pan-cancer cohorts, STKLD1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated STKLD1 data layer compared with 6 for mutation status.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher STKLD1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated STKLD1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and PAAD show a favorable association.
COAD, LUAD, and PAAD are the cancer types where STKLD1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.